✨
AI Summary
- Interview with AstraZeneca's Sharon Barr on biopharma R&D.
- Sanwut Bio's infigratinib Phase III data shared.
- Chinese lawyers analyze US Bio-Safety Act impact.
Guests on This Episode
SB
Sharon Barr
1 podcast appearance
XH
Xu Hu
6 podcast appearances